Jason Stabell
First SEC filing: July 8, 2022 · Latest: July 8, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 21, 2026 | EPSN | P | 13,467 | $5.93 | $79,859 | 642,456 Indirect | +2.14% | Acquired | 1.9% (price as of 2026-10-06) |
| Sept. 18, 2026 | EPSN | P | 1,430 | $5.90 | $8,437 | 628,989 Indirect | +0.23% | Acquired | 2.5% (price as of 2026-10-06) |
| Sept. 16, 2026 | EPSN | P | 8,207 | $5.88 | $48,257 | 627,559 Indirect | +1.33% | Acquired | 2.8% (price as of 2026-10-06) |
| Aug. 24, 2026 | EPSN | P | 21,413 | $5.63 | $120,555 | 619,352 Indirect | +3.58% | Acquired | 7.4% (price as of 2026-10-06) |
| Aug. 21, 2026 | EPSN | P | 4,900 | $5.56 | $27,244 | 597,939 Indirect | +0.83% | Acquired | 8.7% (price as of 2026-10-06) |
| July 2, 2026 | EPSN | A | 18,726 | · | · | 549,682 Direct | +3.53% | Acquired | (price as of 2026-10-06) |
| July 2, 2026 | EPSN | A | 6,094 | · | · | 530,956 Direct | +1.16% | Acquired | (price as of 2026-10-06) |
| June 24, 2026 | EPSN | P | 21,800 | $5.27 | $114,886 | 593,039 Indirect | +3.82% | Acquired | 14.7% (price as of 2026-10-06) |
| June 24, 2026 | EPSN | P | 200 | $5.26 | $1,052 | 571,239 Indirect | +0.04% | Acquired | 14.9% (price as of 2026-10-06) |
| June 22, 2026 | EPSN | P | 18,600 | $5.34 | $99,324 | 571,039 Indirect | +3.37% | Acquired | 13.2% (price as of 2026-10-06) |
| June 22, 2026 | EPSN | P | 9,400 | $5.31 | $49,914 | 552,439 Indirect | +1.73% | Acquired | 13.8% (price as of 2026-10-06) |
| April 1, 2026 | EPSN | A | 6,097 | · | · | 524,862 Direct | +1.18% | Acquired | (price as of 2026-10-06) |
| March 31, 2026 | EPSN | P | 2,000 | $6.17 | $12,340 | 543,039 Indirect | +0.37% | Acquired | -2.0% (price as of 2026-10-06) |
| March 30, 2026 | EPSN | P | 12,000 | $6.22 | $74,640 | 518,765 Direct | +2.37% | Acquired | -2.8% (price as of 2026-10-06) |
| March 27, 2026 | EPSN | P | 6,000 | $6.20 | $37,200 | 541,039 Indirect | +1.12% | Acquired | -2.5% (price as of 2026-10-06) |
| Jan. 22, 2026 | EPSN | A | 166,736 | · | · | 506,765 Direct | +49.04% | Acquired | (price as of 2026-10-06) |
| Jan. 13, 2026 | EPSN | A | 20,007 | · | · | 340,029 Direct | +6.25% | Acquired | (price as of 2026-10-06) |
| Jan. 13, 2026 | EPSN | A | 36,155 | · | · | 320,022 Direct | +12.74% | Acquired | (price as of 2026-10-06) |
| Jan. 13, 2026 | EPSN | A | 6,098 | · | · | 283,867 Direct | +2.20% | Acquired | (price as of 2026-10-06) |
| Dec. 22, 2025 | EPSN | P | 19,100 | $4.59 | $87,669 | 535,039 Indirect | +3.70% | Acquired | 31.7% (price as of 2026-10-06) |
| Dec. 19, 2025 | EPSN | P | 9,400 | $4.62 | $43,428 | 515,939 Indirect | +1.86% | Acquired | 30.8% (price as of 2026-10-06) |
| Nov. 20, 2025 | EPSN | P | 9,700 | $4.77 | $46,269 | 506,539 Indirect | +1.95% | Acquired | 26.7% (price as of 2026-10-06) |
| Nov. 19, 2025 | EPSN | P | 11,500 | $4.82 | $55,430 | 496,839 Indirect | +2.37% | Acquired | 25.4% (price as of 2026-10-06) |
| Oct. 1, 2025 | EPSN | A | 6,098 | · | · | 277,769 Direct | +2.24% | Acquired | (price as of 2026-10-06) |
| Aug. 19, 2025 | EPSN | P | 6,000 | $5.71 | $34,260 | 485,339 Indirect | +1.25% | Acquired | 5.9% (price as of 2026-10-06) |
| Aug. 18, 2025 | EPSN | P | 9,000 | $5.65 | $50,850 | 479,339 Indirect | +1.91% | Acquired | 7.0% (price as of 2026-10-06) |
| July 1, 2025 | EPSN | A | 18,727 | · | · | 271,671 Direct | +7.40% | Acquired | (price as of 2026-10-06) |
| July 1, 2025 | EPSN | A | 6,098 | · | · | 252,944 Direct | +2.47% | Acquired | (price as of 2026-10-06) |
| April 1, 2025 | EPSN | A | 6,098 | · | · | 246,846 Direct | +2.53% | Acquired | (price as of 2026-10-06) |
| Feb. 3, 2025 | EPSN | A | 88,889 | · | · | 240,748 Direct | +58.53% | Acquired | (price as of 2026-10-06) |
| Jan. 6, 2025 | EPSN | A | 36,155 | · | · | 151,859 Direct | +31.25% | Acquired | (price as of 2026-10-06) |
| Jan. 6, 2025 | EPSN | A | 6,098 | · | · | 115,704 Direct | +5.56% | Acquired | (price as of 2026-10-06) |
| Oct. 1, 2024 | EPSN | A | 6,098 | · | · | 109,606 Direct | +5.89% | Acquired | (price as of 2026-10-06) |
| Sept. 18, 2024 | EPSN | P | 74,000 | $5.05 | $373,700 | 470,339 Indirect | +18.67% | Acquired | 19.7% (price as of 2026-10-06) |
| Aug. 16, 2024 | EPSN | P | 9,139 | $5.28 | $48,254 | 396,339 Indirect | +2.36% | Acquired | 14.5% (price as of 2026-10-06) |
| July 12, 2024 | EPSN | A | 18,727 | · | · | 103,508 Direct | +22.09% | Acquired | (price as of 2026-10-06) |
| July 12, 2024 | EPSN | A | 6,098 | · | · | 84,781 Direct | +7.75% | Acquired | (price as of 2026-10-06) |
| May 23, 2024 | EPSN | P | 4,992 | $5.38 | $26,857 | 387,200 Indirect | +1.31% | Acquired | 12.4% (price as of 2026-10-06) |
| May 22, 2024 | EPSN | P | 14,708 | $5.35 | $78,688 | 382,208 Indirect | +4.00% | Acquired | 13.0% (price as of 2026-10-06) |
| May 20, 2024 | EPSN | P | 6,300 | $5.36 | $33,768 | 367,500 Indirect | +1.74% | Acquired | 12.8% (price as of 2026-10-06) |
| April 1, 2024 | EPSN | A | 6,098 | · | · | 78,683 Direct | +8.40% | Acquired | (price as of 2026-10-06) |
| March 27, 2024 | EPSN | P | 17,966 | $5.25 | $94,322 | 361,200 Indirect | +5.23% | Acquired | 15.1% (price as of 2026-10-06) |
| March 26, 2024 | EPSN | P | 18,500 | $5.25 | $97,125 | 343,234 Indirect | +5.70% | Acquired | 15.1% (price as of 2026-10-06) |
| Jan. 30, 2024 | EPSN | P | 245,200 | $4.82 | $1,181,864 | 324,734 Indirect | +308.30% | Acquired | 25.4% (price as of 2026-10-06) |
| Jan. 2, 2024 | EPSN | A | 6,097 | · | · | 72,585 Direct | +9.17% | Acquired | (price as of 2026-10-06) |
| Nov. 17, 2023 | EPSN | P | 7,134 | $5.45 | $38,880 | 79,534 Indirect | +9.85% | Acquired | 10.9% (price as of 2026-10-06) |
| Nov. 16, 2023 | EPSN | P | 9,200 | $5.58 | $51,336 | 72,400 Indirect | +14.56% | Acquired | 8.3% (price as of 2026-10-06) |
| Nov. 15, 2023 | EPSN | P | 9,700 | $5.45 | $52,865 | 63,200 Indirect | +18.13% | Acquired | 10.9% (price as of 2026-10-06) |
| Oct. 2, 2023 | EPSN | A | 6,098 | · | · | 66,488 Direct | +10.10% | Acquired | (price as of 2026-10-06) |
| July 4, 2023 | EPSN | A | 24,390 | · | · | 60,390 Direct | +67.75% | Acquired | (price as of 2026-10-06) |
| June 16, 2023 | EPSN | P | 11,300 | $5.12 | $57,856 | 53,500 Indirect | +26.78% | Acquired | 18.1% (price as of 2026-10-06) |
| June 9, 2023 | EPSN | P | 18,000 | $5.01 | $90,180 | 42,200 Indirect | +74.38% | Acquired | 20.7% (price as of 2026-10-06) |
| May 26, 2023 | EPSN | P | 24,200 | $5.09 | $123,178 | 24,200 Indirect | · | Acquired | 18.8% (price as of 2026-10-06) |
| May 26, 2023 | EPSN | A | 24,200 | $5.09 | $123,178 | 24,200 Indirect | · | Acquired | 18.8% (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 8, 2022 | EPSN | Common Shares | 36,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $311,000 | · | $851,003 | · | · | · | $7,350 | $1,353,353 |
| 2022 | $150,000 | · | $600,000 | · | · | · | $4,346 | $854,346 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.